Related Experiment Video

Updated: Jun 26, 2026

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus
08:32

Development and Assessment of Intracellular Infection Models for Staphylococcus aureus

Published on: January 17, 2025

Staphylococcus aureus: a community pathogen

Loren G Miller1, Sheldon L Kaplan

  • 1Harbor-UCLA Medical Center, Division of Infectious Diseases, Infection Control Program, 1000 W. Carson Street, Box 466, Torrance CA 90509, USA. Lgmiller@ucla.edu

Infectious Disease Clinics of North America
|January 13, 2009
PubMed

Insights

Community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are a growing global concern. This review details the distinct epidemiology and clinical features of CA-MRSA compared to healthcare-associated strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Epidemiology

Background:

  • Staphylococcus aureus is a frequent human pathogen, primarily causing skin infections.
  • The emergence of community-associated methicillin-resistant S aureus (CA-MRSA) has increased global interest in S aureus infections.
  • CA-MRSA exhibits distinct characteristics compared to healthcare-associated methicillin-resistant S aureus (HA-MRSA).

Purpose of the Study:

  • To review the current understanding of the epidemiology of community-associated S aureus infections.
  • To summarize the clinical manifestations of CA-MRSA infections.
  • To differentiate CA-MRSA from HA-MRSA based on pathogenesis, strain characteristics, and epidemiology.

Main Methods:

  • Literature review of epidemiological data.
  • Analysis of clinical case studies.
  • Comparative analysis of CA-MRSA and HA-MRSA characteristics.

Main Results:

  • CA-MRSA strains have unique epidemiological patterns and clinical presentations.
  • CA-MRSA infections are globally prevalent and distinct from HA-MRSA.
  • CA-MRSA shares similarities in behavior with community-associated methicillin-sensitive S aureus (MSSA).

Conclusions:

  • Community-associated S aureus, particularly CA-MRSA, presents unique challenges in epidemiology and clinical management.
  • Understanding the distinct features of CA-MRSA is crucial for effective treatment and control.
  • Further research into CA-MRSA pathogenesis and transmission is warranted.

More Related Videos

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues07:10

A Fluorescence-based Method to Study Bacterial Gene Regulation in Infected Tissues

Published on: February 19, 2019

Related Concept Videos

Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...